Supplementary Materials. Effects of cardiovascular single pill combinations compared with identical multi-pill therapies on healthcare cost and utilization in Germany.
posted on 2022-03-22, 10:25authored byThomas Wilke, Burkhard Weisser, Hans-Georg Predel, Roland E. Schmieder, Sven Wassmann, Anton Gillessen, Jörg Blettenberg, Ulf Maywald, Olaf Randerath, Sabrina Müller, Michael Böhm
Supplemental figure
1: Compares the total number of incapacity days for work per patient year
between SPC and MMPC.
Supplemental figure
2: Comparison of medication costs between SPC and MPC.
Supplemental figure 3: Comparison of costs for
the cure between SPC and MPC
Funding
Funding provided by APONTIS PHARMA Deutschland GmbH & Co. KG, Monheim, Germany.